Eur Rev Med Pharmacol Sci 2019; 23 (1): 328-337

DOI: 10.26355/eurrev_201901_16780

Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy

X.-Y. Li, P. Hu, Q.-Y. Li, M. Zhang, Q.-W. Lai, X. Wang, H.-B. Fan, R.-Q. Yao

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou, Jiangsu Province, China. fandoc@126.com


OBJECTIVE: Autoimmune epilepsy is an under-recognized condition, and the mechanisms of antibody-mediated epileptogenesis are unknown. The N-methyl-D-aspartate (NMDA) receptor subunit 3 peptide B (NR3B) modulates Mg2+ sensitivity and Ca2+ mobilization of glutamate responses in the central nervous system (CNS). The levels of antibodies against NR3B (NR3B Ab’s) in the cerebrospinal fluid (CSF) and the correlations between NR3B Ab’s and cognitive comorbidities of epilepsy patients remain unclear.

PATIENTS AND METHODS: CSF samples were collected from 36 patients with consecutive epilepsy and 17 healthy controls. The levels of NR3B Ab’s in the CSF were measured by ELISA. The cognitive function was assessed by Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE).

RESULTS: The results showed that the levels of NR3B Ab’s were significantly higher in patients with epilepsy than those in the controls (p<0.01). Thirteen of 36 patients had higher levels of NR3B Ab’s exceeding mean+ 2SD of all patients, and the scores of MMSE and MoCA of these 13 patients were significantly lower than the other 23 patients and controls (p<0.01; p<0.001). However, there were no significant differences in the scores of MMSE and MoCA between the 23 patients and the controls. Correlation analysis indicated a significant negative correlation between the levels of NR3B Ab’s and the scores of MMSE (correlation coefficient: r=-0.543; p<0.01) or the scores of MoCA (correlation coefficient: r=-0.548; p<0.01).

CONCLUSIONS: We suggest that some patients with epilepsy may have immune process after onset and the presence of NR3B Ab’s may be associated with cognitive comorbidities in patients with epilepsy.

Free PDF Download

To cite this article

X.-Y. Li, P. Hu, Q.-Y. Li, M. Zhang, Q.-W. Lai, X. Wang, H.-B. Fan, R.-Q. Yao
Correlations between the level of antibody against peptide of glutamate receptor NR3B subunit in the CSF and cognitive comorbidities of patients with epilepsy

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 1
Pages: 328-337
DOI: 10.26355/eurrev_201901_16780